MicroRNA‐150 restores endothelial cell function and attenuates vascular remodeling by targeting PTX3 through the NF‐κB signaling pathway in mice with acute coronary syndrome

MicroRNAs (miRNAs) have been known to function as important regulators in the vascular system, with various physiopathological effects such as vascular remodeling and hypertension modulation. We aimed to explore whether microRNA‐150 (miR‐150) regulates endothelial cell function and vascular remodeling in acute coronary syndrome (ACS), and the involvement of PTX3 and NF‐κB signaling pathway. Ten normal mice and sixty ApoE−/− mice were chosen, and their coronary artery tissues and endothelial cells were extracted. ApoE−/− mice were injected with a series of inhibitor or mimic for miR‐150, or siRNA against PTX3. The miR‐150 expression, NF‐κB1, RELA, and PTX3 mRNA expression were assessed by reverse transcription quantitative polymerase chain reaction, and pentraxin‐3, p‐P50, and p‐P65 protein expression by Western blot analysis. Cell viability and migration were assessed by MTT assay and scratch test. Matrigel tube formation assay was employed to determine vascular remodeling of endothelial cells. The dual‐luciferase reporter assay verified that PTX3 was a target of miR‐150. Mice with ACS presented with decreased miR‐150 but increased PTX3. It was observed that the miR‐150 mimic and siRNA against PTX3 reduced levels of PTX3, NF‐κB1, and RELA in mice, and the miR‐150 inhibitor reversed the tendency. The in vitro cell experimentation proved that miR‐150 might facilitate endothelial cell proliferation, migration, and restrain vascular remodeling via inhibiting PTX3 expression. On the basis of the results of this study, it was hypothesized that miR‐150 could possibly maintain endothelial cell function and suppress vascular remodeling by inhibiting PTX3 through the NF‐κB signaling pathway in mice with ACS.